Zepzelca 4 MG vials
Ended Awarded
- Contract number
- SPE2DR26FQP8N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,081
Award facts
- Contract value 100% obligated
- $10,080.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,080.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Zepzelca 4 mg vials, with completion targeted for December 4, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Zepzelca (tagraxofusp-erzs) is a specialized oncology pharmaceutical used primarily in treating hairy cell leukemia, reflecting AmerisourceBergen's critical role as a prime vendor for military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts spanning brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's SPE2DX master contract serves as a comprehensive global pharmaceutical support vehicle enabling delivery of medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating the breadth of its federal medical supply capabilities.
Quick answers
Who was awarded contract SPE2DR26FQP8N?
SPE2DR26FQP8N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FQP8N worth?
The government has obligated $10,081 on SPE2DR26FQP8N.
Is contract SPE2DR26FQP8N an order under another contract?
Yes. SPE2DR26FQP8N is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP8N competed?
The extent of competition for SPE2DR26FQP8N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award